These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23733106)

  • 21. Effects of the BH3-only protein human Noxa on mitochondrial dynamics.
    Woo HN; Seo YW; Moon AR; Jeong SY; Jeong SY; Choi EK; Kim TH
    FEBS Lett; 2009 Jul; 583(14):2349-54. PubMed ID: 19540835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-guided design of pyridoclax derivatives based on Noxa / Mcl-1 interaction mode.
    Hedir S; De Giorgi M; Fogha J; De Pascale M; Weiswald LB; Brotin E; Marekha B; Denoyelle C; Denis C; Suzanne P; Gautier F; Juin P; Ligat L; Lopez F; Carlier L; Legay R; Bureau R; Rault S; Poulain L; Oliveira Santos JS; Voisin-Chiret AS
    Eur J Med Chem; 2018 Nov; 159():357-380. PubMed ID: 30308410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The fast-mobility isoform of mouse Mcl-1 is a mitochondrial matrix-localized protein with attenuated anti-apoptotic activity.
    Huang CR; Yang-Yen HF
    FEBS Lett; 2010 Aug; 584(15):3323-30. PubMed ID: 20627101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of a neutral peptide aptamer scaffold to anchor BH3 peptides constitutes a viable approach to studying their function.
    Stadler LK; Tomlinson DC; Lee T; Knowles MA; Ko Ferrigno P
    Cell Death Dis; 2014 Jan; 5(1):e1037. PubMed ID: 24481451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands.
    Day CL; Chen L; Richardson SJ; Harrison PJ; Huang DC; Hinds MG
    J Biol Chem; 2005 Feb; 280(6):4738-44. PubMed ID: 15550399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usp9x- and Noxa-mediated Mcl-1 downregulation contributes to pemetrexed-induced apoptosis in human non-small-cell lung cancer cells.
    Yan J; Zhong N; Liu G; Chen K; Liu X; Su L; Singhal S
    Cell Death Dis; 2014 Jul; 5(7):e1316. PubMed ID: 24991768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular analysis of neutrophil spontaneous apoptosis reveals a strong role for the pro-apoptotic BH3-only protein Noxa.
    Kirschnek S; Vier J; Gautam S; Frankenberg T; Rangelova S; Eitz-Ferrer P; Grespi F; Ottina E; Villunger A; Häcker H; Häcker G
    Cell Death Differ; 2011 Nov; 18(11):1805-14. PubMed ID: 21660046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin enhances TRAIL-induced apoptosis by Mcl-1 degradation via Mule in colorectal cancer cells.
    Park SH; Lee DH; Kim JL; Kim BR; Na YJ; Jo MJ; Jeong YA; Lee SY; Lee SI; Lee YY; Oh SC
    Oncotarget; 2016 Sep; 7(37):59503-59518. PubMed ID: 27517746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced killing of melanoma cells by simultaneously targeting Mcl-1 and NOXA.
    Qin JZ; Xin H; Sitailo LA; Denning MF; Nickoloff BJ
    Cancer Res; 2006 Oct; 66(19):9636-45. PubMed ID: 17018621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of NOXA and MCL-1 as a strategy for sensitizing melanoma cells to the BH3-mimetic ABT-737.
    Lucas KM; Mohana-Kumaran N; Lau D; Zhang XD; Hersey P; Huang DC; Weninger W; Haass NK; Allen JD
    Clin Cancer Res; 2012 Feb; 18(3):783-95. PubMed ID: 22173547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear magnetic resonance study of protein-protein interactions involving apoptosis regulator Diva (Boo) and the BH3 domain of proapoptotic Bcl-2 members.
    Santiveri CM; Sborgi L; de Alba E
    J Mol Recognit; 2012 Dec; 25(12):665-73. PubMed ID: 23192964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrion-dependent N-terminal processing of outer membrane Mcl-1 protein removes an essential Mule/Lasu1 protein-binding site.
    Warr MR; Mills JR; Nguyen M; Lemaire-Ewing S; Baardsnes J; Sun KL; Malina A; Young JC; Jeyaraju DV; O'Connor-McCourt M; Pellegrini L; Pelletier J; Shore GC
    J Biol Chem; 2011 Jul; 286(28):25098-107. PubMed ID: 21613222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of MCL-1 Protein Stability Induced by MCL-1 Antagonists in B-Cell Malignancies.
    Tantawy SI; Sarkar A; Hubner S; Tan Z; Wierda WG; Eldeib A; Zhang S; Kornblau S; Gandhi V
    Clin Cancer Res; 2023 Jan; 29(2):446-457. PubMed ID: 36346691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of a putative BH3 domain of clusterin with anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy.
    Lee DH; Ha JH; Kim Y; Bae KH; Park JY; Choi WS; Yoon HS; Park SG; Park BC; Yi GS; Chi SW
    Biochem Biophys Res Commun; 2011 May; 408(4):541-7. PubMed ID: 21527247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting Mcl-1 for multiple myeloma (MM) therapy: drug-induced generation of Mcl-1 fragment Mcl-1(128-350) triggers MM cell death via c-Jun upregulation.
    Fan F; Tonon G; Bashari MH; Vallet S; Antonini E; Goldschmidt H; Schulze-Bergkamen H; Opferman JT; Sattler M; Anderson KC; Jäger D; Podar K
    Cancer Lett; 2014 Feb; 343(2):286-94. PubMed ID: 24120758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BH3-ligand regulates access of MCL-1 to its E3 ligase.
    Warr MR; Acoca S; Liu Z; Germain M; Watson M; Blanchette M; Wing SS; Shore GC
    FEBS Lett; 2005 Oct; 579(25):5603-8. PubMed ID: 16213503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An internal EELD domain facilitates mitochondrial targeting of Mcl-1 via a Tom70-dependent pathway.
    Chou CH; Lee RS; Yang-Yen HF
    Mol Biol Cell; 2006 Sep; 17(9):3952-63. PubMed ID: 16822835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloid cell leukemia 1 (MCL-1): Structural characteristics and application in cancer therapy.
    Mittal P; Singh S; Sinha R; Shrivastava A; Singh A; Singh IK
    Int J Biol Macromol; 2021 Sep; 187():999-1018. PubMed ID: 34339789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MCL-1 promiscuity and the structural resilience of its binding partners.
    Heckmeier PJ; Ruf J; Janković BG; Hamm P
    J Chem Phys; 2023 Mar; 158(9):095101. PubMed ID: 36889945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MARCH5 requires MTCH2 to coordinate proteasomal turnover of the MCL1:NOXA complex.
    Djajawi TM; Liu L; Gong JN; Huang AS; Luo MJ; Xu Z; Okamoto T; Call MJ; Huang DCS; van Delft MF
    Cell Death Differ; 2020 Aug; 27(8):2484-2499. PubMed ID: 32094511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.